Mucinous Ovarian Cancer Mucinous ovarian cancer accounts for 3% of epithelial ovarian
cancers and must be distinguished from mucinous carcinomas that have metastasized to the …

More than 90% of ovarian cancers have been thought to arise from epithelial cells that cover
the ovarian surface or, more frequently, line subserosal cysts. Recent studies suggest that …

Purpose: Early detection would significantly decrease the mortality rate of ovarian cancer. In
this study, we characterize and validate the combination of six serum biomarkers that …

Purpose Invasive mucinous carcinoma of the ovary (mucinous epithelial ovarian cancer
[mEOC]) is a histologic subgroup of epithelial ovarian cancer (EOC). Chemotherapy for …

OBJECTIVES.: The histologic types of epithelial ovarian cancer differ in clinical behavior,
descriptive epidemiology, and genetic origins. The goals of the current study were to …

Mucinous carcinomas are uncommon histological types that affect several organ sites.
Primary mucinous carcinomas of the ovary are distinct from other ovarian carcinoma types …

We established previously that X-linked inhibitor of apoptosis protein (Xiap) is a determinant
of cisplatin (CDDP) resistance in human ovarian cancer cells and that down-regulation of …

Primary ovarian mucinous tumors represent a heterogeneous group of neoplasms, and their
diagnosis may be challenging. We analyzed 124 primary ovarian mucinous tumors …

Genome-wide association studies have identified several risk associations for ovarian
carcinomas but not for mucinous ovarian carcinomas (MOCs). Our analysis of 1,644 MOC …

The objective of the study was to evaluate the prognostic effect of p53, Her-2, and EGFR in
borderline and epithelial ovarian cancer. Tumor tissue from 85 patients with borderline and …